299 related articles for article (PubMed ID: 29932236)
1. Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats.
Zhou S; Liu YG; Zhang Y; Hu JM; Liu D; Chen H; Li M; Guo Y; Fan LP; Li LY; Zhao M
J Cell Biochem; 2018 Nov; 119(10):8220-8232. PubMed ID: 29932236
[TBL] [Abstract][Full Text] [Related]
2. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury.
Li J; Guo W; Xiong M; Han H; Chen J; Mao D; Tang B; Yu H; Zeng Y
Int J Mol Med; 2015 Nov; 36(5):1205-14. PubMed ID: 26398409
[TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment.
Liu N; Tian J; Cheng J; Zhang J
Exp Cell Res; 2013 Aug; 319(13):2019-2027. PubMed ID: 23624354
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
[TBL] [Abstract][Full Text] [Related]
5. Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats.
Li X; An G; Wang Y; Liang D; Zhu Z; Tian L
Stem Cell Res Ther; 2018 Dec; 9(1):335. PubMed ID: 30514375
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue.
Zhong Z; Li K; Shen C; Ma Y; Guo L
Hum Cell; 2024 Jan; 37(1):214-228. PubMed ID: 37968533
[TBL] [Abstract][Full Text] [Related]
7. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation.
Liu N; Han G; Cheng J; Huang J; Tian J
Exp Biol Med (Maywood); 2013 Jun; 238(6):678-86. PubMed ID: 23918879
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury.
Zhou S; Qiao YM; Liu YG; Liu D; Hu JM; Liao J; Li M; Guo Y; Fan LP; Li LY; Zhao M
Cell Biosci; 2020 Nov; 10(1):130. PubMed ID: 33292452
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Study of Bone Marrow-Derived Mesenchymal Stem Cells Pretreatment With Erythropoietin in Preventing Acute Rejection After Rat Renal Transplantation.
Zhang Y; Zhou S; Hu JM; Chen H; Liu D; Li M; Guo Y; Fan LP; Li LY; Liu YG; Zhao M
Transplant Proc; 2018 Dec; 50(10):3873-3880. PubMed ID: 30577280
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury.
Liu N; Patzak A; Zhang J
Am J Physiol Renal Physiol; 2013 Oct; 305(7):F1064-73. PubMed ID: 23884141
[TBL] [Abstract][Full Text] [Related]
12. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.
Liu N; Tian J; Cheng J; Zhang J
J Cell Biochem; 2013 Dec; 114(12):2677-89. PubMed ID: 23794207
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway.
Bing W; Pang X; Qu Q; Bai X; Yang W; Bi Y; Bi X
J Cell Mol Med; 2016 May; 20(5):949-61. PubMed ID: 26871266
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Migration of Bone Marrow-Derived Mesenchymal Stem Cells with Tetramethylpyrazine and Its Synergistic Effect on Angiogenesis and Neurogenesis After Cerebral Ischemia in Rats.
Li L; Chu L; Ren C; Wang J; Sun S; Li T; Yin Y
Stem Cells Dev; 2019 Jul; 28(13):871-881. PubMed ID: 31038013
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.
Yu X; Lu C; Liu H; Rao S; Cai J; Liu S; Kriegel AJ; Greene AS; Liang M; Ding X
PLoS One; 2013; 8(5):e62703. PubMed ID: 23671625
[TBL] [Abstract][Full Text] [Related]
16. [The effect of recombinant human erythropoietin on the migration of bone marrow derived mesenchymal stem cells in vitro].
Chen L; Cheng FJ; Tang JM
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):811-4. PubMed ID: 19176034
[TBL] [Abstract][Full Text] [Related]
17. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
18. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.
Klopsch C; Skorska A; Ludwig M; Lemcke H; Maass G; Gaebel R; Beyer M; Lux C; Toelk A; Müller K; Maschmeier C; Rohde S; Mela P; Müller-Hilke B; Jockenhoevel S; Vollmar B; Jaster R; David R; Steinhoff G
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752300
[TBL] [Abstract][Full Text] [Related]
19. Klotho gene-modified BMSCs showed elevated antifibrotic effects by inhibiting the Wnt/β-catenin pathway in kidneys after acute injury.
Zhang F; Wan X; Cao YZ; Sun D; Cao CC
Cell Biol Int; 2018 Dec; 42(12):1670-1679. PubMed ID: 30358003
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression.
Mo SJ; Zhong Q; Zhou YF; Deng DB; Zhang XQ
Neurosci Lett; 2012 Aug; 522(2):92-7. PubMed ID: 22698588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
